skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 119  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page
Refined by: Database: Taylor & Francis Open Access remove language: Japanese remove
Result Number Material Type Add to My Shelf Action Record Details and Options
21
Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure
Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure
Material Type:
Article 		Add to My Research

Soluble, platelet-bound, and total P-selectin as indices of platelet activation in congestive heart failure

Annals of medicine (Helsinki), 2009, Vol.41 (1), p.45-51 [Peer Reviewed Journal]

2009 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2009 ;2009 INIST-CNRS ;ISSN: 0785-3890 ;EISSN: 1365-2060 ;DOI: 10.1080/07853890802227089 ;PMID: 18618353

Digital Resources/Online E-Resources

Citations Cited by
22
Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes
Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes
Material Type:
Article 		Add to My Research

Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes

Communicative & integrative biology, , Vol.6 (4), p.e24511-e24511 [Peer Reviewed Journal]

Copyright © 2013 Landes Bioscience 2013 ;ISSN: 1942-0889 ;EISSN: 1942-0889 ;DOI: 10.4161/cib.24511 ;PMID: 23986804

Full text available

Citations Cited by
23
Influence of socioeconomic factors on hospital readmissions for heart failure and acute myocardial infarction in patients 65 years and older: evidence from a systematic review
Influence of socioeconomic factors on hospital readmissions for heart failure and acute myocardial infarction in patients 65 years and older: evidence from a systematic review
Material Type:
Article 		Add to My Research

Influence of socioeconomic factors on hospital readmissions for heart failure and acute myocardial infarction in patients 65 years and older: evidence from a systematic review

Clinical interventions in aging, 2015-01, Vol.10, p.237-245 [Peer Reviewed Journal]

COPYRIGHT 2015 Dove Medical Press Limited ;COPYRIGHT 2015 Dove Medical Press Limited ;2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Damiani et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/cia.s71165 ;PMID: 25653510

Full text available

Citations Cited by
24
Emerging therapeutic targets for cardiac hypertrophy
Emerging therapeutic targets for cardiac hypertrophy
Material Type:
Article 		Add to My Research

Emerging therapeutic targets for cardiac hypertrophy

Expert opinion on therapeutic targets, 2022-01, Vol.26 (1), p.29-40 [Peer Reviewed Journal]

2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;ISSN: 1472-8222 ;EISSN: 1744-7631 ;DOI: 10.1080/14728222.2022.2031974 ;PMID: 35076342

Digital Resources/Online E-Resources

Citations Cited by
25
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers
Material Type:
Article 		Add to My Research

Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markers

Vascular health and risk management, 2008-06, Vol.4 (3), p.575-596 [Peer Reviewed Journal]

2008. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2008 Ban and Twigg, publisher and licensee Dove Medical Press Ltd. 2008 ;ISSN: 1176-6344 ;ISSN: 1178-2048 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s1991 ;PMID: 18827908

Full text available

Citations Cited by
26
Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD - Real-World Data from a Primary Care Setting
Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD - Real-World Data from a Primary Care Setting
Material Type:
Article 		Add to My Research

Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD - Real-World Data from a Primary Care Setting

International journal of chronic obstructive pulmonary disease, 2020-01, Vol.15, p.235-245 [Peer Reviewed Journal]

2020 Ellingsen et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Ellingsen et al. 2020 Ellingsen et al. ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/copd.s231296 ;PMID: 32099348

Full text available

Citations Cited by
27
Fetal ductus arteriosus constriction and closure: analysis of the causes and perinatal outcome related to 45 consecutive cases
Fetal ductus arteriosus constriction and closure: analysis of the causes and perinatal outcome related to 45 consecutive cases
Material Type:
Article 		Add to My Research

Fetal ductus arteriosus constriction and closure: analysis of the causes and perinatal outcome related to 45 consecutive cases

The journal of maternal-fetal & neonatal medicine, 2016-02, Vol.29 (4), p.638-645 [Peer Reviewed Journal]

2015 Informa UK Ltd. 2015 ;ISSN: 1476-7058 ;EISSN: 1476-4954 ;DOI: 10.3109/14767058.2015.1015413 ;PMID: 25708490

Digital Resources/Online E-Resources

Citations Cited by
28
Novel Treatments from Inhibition of the Intestinal Sodium–Hydrogen Exchanger 3
Novel Treatments from Inhibition of the Intestinal Sodium–Hydrogen Exchanger 3
Material Type:
Article 		Add to My Research

Novel Treatments from Inhibition of the Intestinal Sodium–Hydrogen Exchanger 3

International journal of nephrology and renovascular disease, 2021-12, Vol.14, p.411-420 [Peer Reviewed Journal]

COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Kovesdy et al. 2021 Kovesdy et al. ;ISSN: 1178-7058 ;EISSN: 1178-7058 ;DOI: 10.2147/IJNRD.S334024 ;PMID: 34880650

Full text available

Citations Cited by
29
The clinical usefulness of central hemodynamics to evaluate diastolic dysfunction in subjects without hypertension
The clinical usefulness of central hemodynamics to evaluate diastolic dysfunction in subjects without hypertension
Material Type:
Article 		Add to My Research

The clinical usefulness of central hemodynamics to evaluate diastolic dysfunction in subjects without hypertension

Clinical interventions in aging, 2014-01, Vol.9, p.527-533 [Peer Reviewed Journal]

COPYRIGHT 2014 Dove Medical Press Limited ;COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Kim et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/cia.s58810 ;PMID: 24729693

Full text available

Citations Cited by
30
Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
Material Type:
Article 		Add to My Research

Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity

International journal of nanomedicine, 2019-01, Vol.14, p.6061-6071 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Zhang et al. 2019 Zhang et al. ;ISSN: 1178-2013 ;ISSN: 1176-9114 ;EISSN: 1178-2013 ;DOI: 10.2147/IJN.S211130 ;PMID: 31534336

Full text available

Citations Cited by
31
Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure
Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure
Material Type:
Article 		Add to My Research

Oxidative stress and ischemia-modified albumin in chronic ischemic heart failure

Redox report : communications in free radical research, 2014-05, Vol.19 (3), p.118-123 [Peer Reviewed Journal]

W. S. Maney & Son Ltd 2014 2014 ;W. S. Maney & Son Ltd 2014 2014 W. S. Maney & Son Ltd 2014 ;ISSN: 1351-0002 ;EISSN: 1743-2928 ;DOI: 10.1179/1351000213Y.0000000083 ;PMID: 24620936

Full text available

Citations Cited by
32
Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor
Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor
Material Type:
Article 		Add to My Research

Edaravone inhibits pressure overload-induced cardiac fibrosis and dysfunction by reducing expression of angiotensin II AT1 receptor

Drug design, development and therapy, 2017-01, Vol.11, p.3019-3033 [Peer Reviewed Journal]

2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Zhang et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/dddt.s144807 ;PMID: 29081650

Full text available

Citations Cited by
33
Validity of Claims Diagnosis Codes for Cardiovascular Diseases in Diabetes Patients in Japanese Administrative Database
Validity of Claims Diagnosis Codes for Cardiovascular Diseases in Diabetes Patients in Japanese Administrative Database
Material Type:
Article 		Add to My Research

Validity of Claims Diagnosis Codes for Cardiovascular Diseases in Diabetes Patients in Japanese Administrative Database

Clinical epidemiology, 2020-01, Vol.12, p.367-375 [Peer Reviewed Journal]

2020 Ono et al. ;COPYRIGHT 2020 Dove Medical Press Limited ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Ono et al. 2020 Ono et al. ;ISSN: 1179-1349 ;EISSN: 1179-1349 ;DOI: 10.2147/clep.s245555 ;PMID: 32308492

Full text available

Citations Cited by
34
Spirolactone provides protection from renal fibrosis by inhibiting the endothelial-mesenchymal transition in isoprenaline-induced heart failure in rats
Spirolactone provides protection from renal fibrosis by inhibiting the endothelial-mesenchymal transition in isoprenaline-induced heart failure in rats
Material Type:
Article 		Add to My Research

Spirolactone provides protection from renal fibrosis by inhibiting the endothelial-mesenchymal transition in isoprenaline-induced heart failure in rats

Drug design, development and therapy, 2016-01, Vol.10 (Issue 1), p.1581-1588 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Zhou et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/dddt.s100095 ;PMID: 27217725

Full text available

Citations Cited by
35
Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
Material Type:
Article 		Add to My Research

Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis

Drug design, development and therapy, 2019-05, Vol.13, p.1515-1525 [Peer Reviewed Journal]

COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Mathew and Wang. This work is published and licensed by Dove Medical Press Limited 2019 ;ISSN: 1177-8881 ;EISSN: 1177-8881 ;DOI: 10.2147/dddt.s162913 ;PMID: 31118583

Full text available

Citations Cited by
36
Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI
Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI
Material Type:
Article 		Add to My Research

Proprotein Convertase Subtilisin/Kexin Type 9 and Systemic Inflammatory Biomarker Pentraxin 3 for Risk Stratification Among STEMI Patients Undergoing Primary PCI

Journal of inflammation research, 2021-01, Vol.14, p.5319-5335 [Peer Reviewed Journal]

2021 Zhao et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Zhao et al. 2021 Zhao et al. ;ISSN: 1178-7031 ;EISSN: 1178-7031 ;DOI: 10.2147/jir.s334246 ;PMID: 34703271

Full text available

Citations Cited by
37
The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis
The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis
Material Type:
Article 		Add to My Research

The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis

Vascular health and risk management, 2021-01, Vol.17, p.601-617 [Peer Reviewed Journal]

2021 Chauin. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Chauin. 2021 Chauin. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s327661 ;PMID: 34584417

Full text available

Citations Cited by
38
Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over Time
Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over Time
Material Type:
Article 		Add to My Research

Charlson Comorbidity Index Based On Hospital Episode Statistics Performs Adequately In Predicting Mortality, But Its Discriminative Ability Diminishes Over Time

Clinical epidemiology, , Vol.11, p.923-932 [Peer Reviewed Journal]

2019 Pylväläinen et al. ;COPYRIGHT 2019 Dove Medical Press Limited ;COPYRIGHT 2019 Dove Medical Press Limited ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Pylväläinen et al. 2019 Pylväläinen et al. ;ISSN: 1179-1349 ;EISSN: 1179-1349 ;DOI: 10.2147/clep.s218697 ;PMID: 31695505

Full text available

Citations Cited by
39
Relationship between abnormal P-wave terminal force in lead V1 and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study
Relationship between abnormal P-wave terminal force in lead V1 and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study
Material Type:
Article 		Add to My Research

Relationship between abnormal P-wave terminal force in lead V1 and left ventricular diastolic dysfunction in hypertensive patients: the LIFE study

Blood pressure, 2017-03, Vol.26 (2), p.94-101 [Peer Reviewed Journal]

2016 Informa UK Limited, trading as Taylor & Francis Group 2016 ;ISSN: 0803-7051 ;EISSN: 1651-1999 ;DOI: 10.1080/08037051.2016.1215765

Digital Resources/Online E-Resources

Citations Cited by
40
Activation of Notch signaling in cardiomyocytes during post-infarction remodeling
Activation of Notch signaling in cardiomyocytes during post-infarction remodeling
Material Type:
Article 		Add to My Research

Activation of Notch signaling in cardiomyocytes during post-infarction remodeling

Scandinavian cardiovascular journal : SCJ, 2010-12, Vol.44 (6), p.359 [Peer Reviewed Journal]

EISSN: 1651-2006 ;DOI: 10.3109/14017431.2010.511256 ;PMID: 20799913

Digital Resources/Online E-Resources

Citations Cited by

Results 21 - 40 of 119  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2000  (7)
  2. 2000 To 2006  (7)
  3. 2007 To 2011  (19)
  4. 2012 To 2017  (52)
  5. After 2017  (35)
  6. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait